vortioxetine 10 mg tablet

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

2 competitors in Attention Deficit Hyperactivity Disorder

Drug Information

Target Indication

Attention Deficit Hyperactivity Disorder

Clinical Trial

Last updated: 12/23/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

HLUYY

Lundbeck

Related Pipeline

Major Depressive Disorder

Multiple System Atrophy

Acute Ischemic Stroke

Major Depression Disorder

Major Depressive Disorder

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts